Sulzer (SUN) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
2 Nov, 2025Executive summary
Year-to-date order intake declined by 1.2%, showing improvement from H1 2025's -2.4%.
Positive momentum in order intake, with some large projects postponed to 2026.
Financial highlights
Total order intake for Jan–Sep 2025 was CHF 2,777 million, down from CHF 2,934 million year-over-year.
Services division order intake grew 13.2% year-over-year, reaching CHF 1,106 million.
Flow division order intake decreased by 2.3% year-over-year to CHF 1,139 million.
Chemtech division order intake dropped 20.3% year-over-year to CHF 533 million.
Outlook and guidance
Full-year guidance confirmed: organic order intake growth of 2% to 5% and sales growth of 5% to 8%.
EBITDA margin expected to exceed 15% of sales.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sulzer
- Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
Q4 202526 Feb 2026 - Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 20242 Feb 2026 - Targets above-market growth, >17% EBITDA margin, and >22% ROCE by 2028, fully self-financed.SUN
CMD 20241 Feb 2026 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 202416 Dec 2025 - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 202524 Jul 2025 - Stable Q1 order intake and confirmed guidance, with strong Flow and Services growth.SUN
Q1 2025 TU23 Jun 2025 - Order intake up 9.2% year-over-year; full-year guidance and profitability targets reaffirmed.SUN
Q3 2024 TU13 Jun 2025